Home / Market News / $SRTS

$SRTS news and market catalysts

The 5 most recent market catalysts affecting $SRTS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 3 high impact 0 bullish 5 bearish Healthcare
Nov 13, 2026 Corporate Catalyst Bearish Impact 92
Sensus Healthcare Reports Third Quarter 2026 Financial Results
Sensus Healthcare announced its third-quarter 2026 financial results, reporting an EPS of $(0.09), which was worse than the analyst consensus of a $(0.06) loss. Additionally, quart…
Nov 1, 2026 Corporate Catalyst Bearish Impact 85
Sensus Healthcare Reports Q2 2026 Financial Results and Analyst Rating Update
Sensus Healthcare (SRTS) announced disappointing Q2 2026 financial results, characterized by a significant revenue drop and an adjusted net loss. This underperformance was directly…
Aug 14, 2026 Corporate Catalyst Bearish Impact 55
Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $4
Lake Street analyst Ben Haynor maintained a 'Buy' rating on Sensus Healthcare (SRTS) but lowered the price target from $4.50 to $4.00. This action signals a slight reduction in the…
Aug 13, 2026 Corporate Catalyst Bearish Impact 75
Sensus Healthcare shares are trading lower after the company reported worse-than-expected Q2 financial results.
This headline indicates a direct corporate catalyst impacting Sensus Healthcare (SRTS). Worse-than-expected financial results typically lead to immediate negative price action as i…
Aug 13, 2026 Corporate Catalyst Bearish Impact 95
Sensus Healthcare Q2 EPS $(0.53) Misses $(0.13) Estimate, Sales $2.290M Miss $4.601M Estimate
Sensus Healthcare (SRTS) announced Q2 results that were dramatically below analyst expectations, with EPS missing by 341.67% and sales by 50.23%. This poor performance is further e…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.